China NMPA Product Recall - G30/G40 Patient Monitor

Philips Kinco (Shenzhen) Industrial Co., Ltd. has initiated a voluntary Class III recall of its G30/G40 patient monitors, as announced by the National Medical Products Administration (NMPA) on June 10, 2022. The recall specifically targets devices equipped with software versions 9.32.02, 9.32.03, 9.32.031, and 9.32.32. The company's internal monitoring identified that these specific software versions failed to comply with established standards. While no external inspection dates are provided, the recall stems from the company's internal quality assurance processes uncovering the non-compliance, leading to this proactive measure. Operating under the oversight of the NMPA, the regulatory body in China responsible for medical devices, Philips Kinco (Shenzhen) Industrial Co., Ltd. is required to remove the affected products from the market. The Class III designation indicates that the non-compliance is unlikely to cause adverse health consequences, but corrective action is still necessary to ensure product quality and adherence to regulatory requirements. The company must provide detailed information on affected models and batches through a "Medical Device Recall Event Report Form" to facilitate the recall process. This action underscores the importance of ongoing product monitoring and adherence to safety and performance standards within the medical device industry.